See you next year! October 2025
JapanDelivered as a Hybrid Event
Vivian LeeSenior Research Scientist, Protein Therapeutics at Gilead SciencesSpeaker
Profile
Vivian Lee has over 20 years drug development experiences in biotech/pharmaceutical industry including Onyx Pharmaceuticals, Genentech and 23andme. She has established human synthetic antibody phage libraries, a two in one antibody technology, T-cell engager platforms and lead optimization strategies. She currently works as Senior Research Scientist in Protein Therapeutics Department at Gilead Sciences, leading biologics discovery in various therapeutic areas including oncology, inflammation and virology.
Agenda Sessions
Unleashing Therapeutic Potential: Bispecific Antibodies Targeting Herpes Simplex Virus Infection for Chronic Suppressive Therapy
, 15:00View Session